从医保支付视角来看,医药行业的核心支付品种集中于慢性病、肿瘤、罕见病及重大疾病创新药,其背后涉及国内外药企的激烈竞争与政策协同。结合最新医保目录及行业数据,重点品种及厂家分析如下:一、糖尿病用药:医保支付规模最大品类市场规模:2024年上半年公立医疗机构口服糖尿病化药销售额超250亿元,同比增长7.75%。核心品种及厂家:1. 达格列净片(SGLT2抑制剂)厂家:阿斯利康(原研)、浙江华海药业、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.